16-56878991-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001126108.2(SLC12A3):c.1181-82C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 1,506,828 control chromosomes in the GnomAD database, including 28,048 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.18 ( 2524 hom., cov: 32)
Exomes 𝑓: 0.19 ( 25524 hom. )
Consequence
SLC12A3
NM_001126108.2 intron
NM_001126108.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.975
Publications
13 publications found
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Gene-Disease associations (from GenCC):
- Gitelman syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 16-56878991-C-T is Benign according to our data. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56878991-C-T is described in CliVar as Benign. Clinvar id is 1233940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1181-82C>T | intron_variant | Intron 9 of 25 | ENST00000563236.6 | NP_001119580.2 | ||
SLC12A3 | NM_000339.3 | c.1181-82C>T | intron_variant | Intron 9 of 25 | NP_000330.3 | |||
SLC12A3 | NM_001126107.2 | c.1178-82C>T | intron_variant | Intron 9 of 25 | NP_001119579.2 | |||
SLC12A3 | NM_001410896.1 | c.1178-82C>T | intron_variant | Intron 9 of 25 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1181-82C>T | intron_variant | Intron 9 of 25 | 1 | NM_001126108.2 | ENSP00000456149.2 | |||
SLC12A3 | ENST00000438926.6 | c.1181-82C>T | intron_variant | Intron 9 of 25 | 1 | ENSP00000402152.2 | ||||
SLC12A3 | ENST00000566786.5 | c.1178-82C>T | intron_variant | Intron 9 of 25 | 1 | ENSP00000457552.1 | ||||
SLC12A3 | ENST00000262502.5 | c.1178-82C>T | intron_variant | Intron 9 of 25 | 5 | ENSP00000262502.5 |
Frequencies
GnomAD3 genomes AF: 0.177 AC: 26942AN: 152102Hom.: 2520 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
26942
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.193 AC: 260995AN: 1354608Hom.: 25524 AF XY: 0.194 AC XY: 129936AN XY: 670716 show subpopulations
GnomAD4 exome
AF:
AC:
260995
AN:
1354608
Hom.:
AF XY:
AC XY:
129936
AN XY:
670716
show subpopulations
African (AFR)
AF:
AC:
3306
AN:
30834
American (AMR)
AF:
AC:
9551
AN:
35756
Ashkenazi Jewish (ASJ)
AF:
AC:
4848
AN:
24896
East Asian (EAS)
AF:
AC:
9290
AN:
35782
South Asian (SAS)
AF:
AC:
16458
AN:
78252
European-Finnish (FIN)
AF:
AC:
9762
AN:
47968
Middle Eastern (MID)
AF:
AC:
883
AN:
4010
European-Non Finnish (NFE)
AF:
AC:
195684
AN:
1040664
Other (OTH)
AF:
AC:
11213
AN:
56446
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11617
23234
34850
46467
58084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6920
13840
20760
27680
34600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.177 AC: 26955AN: 152220Hom.: 2524 Cov.: 32 AF XY: 0.181 AC XY: 13493AN XY: 74408 show subpopulations
GnomAD4 genome
AF:
AC:
26955
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
13493
AN XY:
74408
show subpopulations
African (AFR)
AF:
AC:
4736
AN:
41542
American (AMR)
AF:
AC:
3787
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
666
AN:
3470
East Asian (EAS)
AF:
AC:
1350
AN:
5174
South Asian (SAS)
AF:
AC:
1023
AN:
4820
European-Finnish (FIN)
AF:
AC:
2135
AN:
10592
Middle Eastern (MID)
AF:
AC:
61
AN:
292
European-Non Finnish (NFE)
AF:
AC:
12634
AN:
68012
Other (OTH)
AF:
AC:
441
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1153
2306
3460
4613
5766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
818
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.